

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | vascular endothelial growth factor signaling pathway (GO:0038084) | 6.44244697 |
| 2 | lymph vessel development (GO:0001945) | 6.10050025 |
| 3 | angiogenesis involved in wound healing (GO:0060055) | 5.67489645 |
| 4 | Notch signaling involved in heart development (GO:0061314) | 5.66352259 |
| 5 | endothelium development (GO:0003158) | 5.42602187 |
| 6 | regulation of cell migration involved in sprouting angiogenesis (GO:0090049) | 5.23852616 |
| 7 | glomerular visceral epithelial cell development (GO:0072015) | 5.21810615 |
| 8 | ventricular trabecula myocardium morphogenesis (GO:0003222) | 5.10910032 |
| 9 | retina vasculature morphogenesis in camera-type eye (GO:0061299) | 4.89070511 |
| 10 | cellular response to vascular endothelial growth factor stimulus (GO:0035924) | 4.81626254 |
| 11 | lymphangiogenesis (GO:0001946) | 4.59271030 |
| 12 | glomerular epithelial cell development (GO:0072310) | 4.58584520 |
| 13 | heart trabecula morphogenesis (GO:0061384) | 4.48857869 |
| 14 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 4.44145678 |
| 15 | glomerular basement membrane development (GO:0032836) | 4.42009007 |
| 16 | cell migration involved in sprouting angiogenesis (GO:0002042) | 4.30016787 |
| 17 | positive regulation of protein kinase C signaling (GO:0090037) | 4.26423264 |
| 18 | surfactant homeostasis (GO:0043129) | 4.19919482 |
| 19 | trabecula morphogenesis (GO:0061383) | 4.12608501 |
| 20 | negative regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030948) | 4.05890156 |
| 21 | positive regulation of vasculogenesis (GO:2001214) | 4.02211657 |
| 22 | hyaluronan catabolic process (GO:0030214) | 3.98425209 |
| 23 | blood vessel endothelial cell migration (GO:0043534) | 3.96421212 |
| 24 | regulation of blood vessel endothelial cell migration (GO:0043535) | 3.96145026 |
| 25 | positive regulation of endothelial cell differentiation (GO:0045603) | 3.92916919 |
| 26 | vascular endothelial growth factor receptor signaling pathway (GO:0048010) | 3.85574937 |
| 27 | blood vessel maturation (GO:0001955) | 3.78863070 |
| 28 | lysine metabolic process (GO:0006553) | 3.73340866 |
| 29 | lysine catabolic process (GO:0006554) | 3.73340866 |
| 30 | patterning of blood vessels (GO:0001569) | 3.72231050 |
| 31 | fatty acid transmembrane transport (GO:1902001) | 3.68064936 |
| 32 | cardiac myofibril assembly (GO:0055003) | 3.65411049 |
| 33 | heart trabecula formation (GO:0060347) | 3.63374088 |
| 34 | basement membrane organization (GO:0071711) | 3.63253268 |
| 35 | transcytosis (GO:0045056) | 3.61346246 |
| 36 | gap junction assembly (GO:0016264) | 3.53347295 |
| 37 | heart valve formation (GO:0003188) | 3.50594482 |
| 38 | semaphorin-plexin signaling pathway (GO:0071526) | 3.48758236 |
| 39 | negative regulation of epithelial cell migration (GO:0010633) | 3.48612630 |
| 40 | renal filtration (GO:0097205) | 3.45882012 |
| 41 | wound healing, spreading of epidermal cells (GO:0035313) | 3.41877313 |
| 42 | endothelial cell morphogenesis (GO:0001886) | 3.41011778 |
| 43 | regulation of vasculogenesis (GO:2001212) | 3.38593352 |
| 44 | chemical homeostasis within a tissue (GO:0048875) | 3.38367019 |
| 45 | venous blood vessel morphogenesis (GO:0048845) | 3.38176927 |
| 46 | glomerular filtration (GO:0003094) | 3.37263534 |
| 47 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 3.35781023 |
| 48 | L-phenylalanine catabolic process (GO:0006559) | 3.35781023 |
| 49 | Notch receptor processing (GO:0007220) | 3.35098281 |
| 50 | negative regulation of angiogenesis (GO:0016525) | 3.35024266 |
| 51 | glyoxylate metabolic process (GO:0046487) | 3.34156705 |
| 52 | endothelial cell proliferation (GO:0001935) | 3.32701750 |
| 53 | regulation of endothelial cell migration (GO:0010594) | 3.31405814 |
| 54 | coronary vasculature morphogenesis (GO:0060977) | 3.31146417 |
| 55 | negative regulation of fibrinolysis (GO:0051918) | 3.30706726 |
| 56 | L-phenylalanine metabolic process (GO:0006558) | 3.29792231 |
| 57 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 3.29792231 |
| 58 | establishment of endothelial barrier (GO:0061028) | 3.28464295 |
| 59 | regulation of endothelial cell differentiation (GO:0045601) | 3.28110250 |
| 60 | plasma membrane repair (GO:0001778) | 3.27863256 |
| 61 | adenosine receptor signaling pathway (GO:0001973) | 3.27648001 |
| 62 | sprouting angiogenesis (GO:0002040) | 3.23886097 |
| 63 | carnitine shuttle (GO:0006853) | 3.23215046 |
| 64 | negative regulation of blood vessel morphogenesis (GO:2000181) | 3.21078238 |
| 65 | nephron epithelium development (GO:0072009) | 3.14581121 |
| 66 | sarcomere organization (GO:0045214) | 3.14300770 |
| 67 | regulation of fibrinolysis (GO:0051917) | 3.12426665 |
| 68 | endothelial cell chemotaxis (GO:0035767) | 3.12026972 |
| 69 | regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030947) | 3.11056857 |
| 70 | positive regulation of odontogenesis (GO:0042482) | 3.10394223 |
| 71 | angiogenesis (GO:0001525) | 3.09911603 |
| 72 | alpha-linolenic acid metabolic process (GO:0036109) | 3.09062820 |
| 73 | mRNA transcription from RNA polymerase II promoter (GO:0042789) | 3.08511904 |
| 74 | myofibril assembly (GO:0030239) | 3.06909564 |
| 75 | protein localization to endosome (GO:0036010) | 3.06378854 |
| 76 | morphogenesis of an endothelium (GO:0003159) | 3.04358738 |
| 77 | endothelial tube morphogenesis (GO:0061154) | 3.04358738 |
| 78 | glomerulus development (GO:0032835) | 3.02556477 |
| 79 | negative regulation of vasculature development (GO:1901343) | 3.01409385 |
| 80 | cAMP biosynthetic process (GO:0006171) | 2.99910484 |
| 81 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 2.98897892 |
| 82 | fatty acid beta-oxidation (GO:0006635) | 2.98473450 |
| 83 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 2.98135524 |
| 84 | dichotomous subdivision of an epithelial terminal unit (GO:0060600) | 2.97144733 |
| 85 | aorta morphogenesis (GO:0035909) | 2.97014302 |
| 86 | phospholipid homeostasis (GO:0055091) | 2.96439701 |
| 87 | kynurenine metabolic process (GO:0070189) | 2.95609430 |
| 88 | 2-oxoglutarate metabolic process (GO:0006103) | 2.95092561 |
| 89 | neuron projection extension involved in neuron projection guidance (GO:1902284) | 2.94499682 |
| 90 | axon extension involved in axon guidance (GO:0048846) | 2.94499682 |
| 91 | regulation of protein activation cascade (GO:2000257) | 2.94254736 |
| 92 | endothelial cell differentiation (GO:0045446) | 2.93900419 |
| 93 | peptidyl-glutamic acid carboxylation (GO:0017187) | 2.90674147 |
| 94 | protein carboxylation (GO:0018214) | 2.90674147 |
| 95 | aromatic amino acid family catabolic process (GO:0009074) | 2.90572749 |
| 96 | protein kinase C signaling (GO:0070528) | 2.89585950 |
| 97 | endothelial cell migration (GO:0043542) | 2.89352633 |
| 98 | positive regulation of Rap GTPase activity (GO:0032854) | 2.85606458 |
| 99 | aspartate family amino acid catabolic process (GO:0009068) | 2.84386531 |
| 100 | negative regulation of Rho protein signal transduction (GO:0035024) | 2.84275969 |
| 101 | peptidyl-tyrosine autophosphorylation (GO:0038083) | 2.84089930 |
| 102 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 2.83847009 |
| 103 | positive regulation of urine volume (GO:0035810) | 2.83736259 |
| 104 | regulation of complement activation (GO:0030449) | 2.83636835 |
| 105 | ovulation from ovarian follicle (GO:0001542) | 2.81529544 |
| 106 | negative regulation of blood vessel endothelial cell migration (GO:0043537) | 2.81447391 |
| 107 | vasculogenesis (GO:0001570) | 2.80386967 |
| 108 | negative regulation of hemostasis (GO:1900047) | 2.79557697 |
| 109 | negative regulation of blood coagulation (GO:0030195) | 2.79557697 |
| 110 | positive regulation of fatty acid oxidation (GO:0046321) | 2.79254788 |
| 111 | high-density lipoprotein particle remodeling (GO:0034375) | 2.79105665 |
| 112 | fatty acid oxidation (GO:0019395) | 2.77420509 |
| 113 | regulation of triglyceride catabolic process (GO:0010896) | 2.77104031 |
| 114 | regulation of sequestering of triglyceride (GO:0010889) | 2.76275313 |
| 115 | positive regulation of endothelial cell proliferation (GO:0001938) | 2.75027765 |
| 116 | positive regulation of receptor recycling (GO:0001921) | 2.72519910 |
| 117 | negative regulation of focal adhesion assembly (GO:0051895) | 2.71065105 |
| 118 | negative regulation of cell junction assembly (GO:1901889) | 2.71065105 |
| 119 | negative regulation of adherens junction organization (GO:1903392) | 2.71065105 |
| 120 | amino-acid betaine metabolic process (GO:0006577) | 2.70927939 |
| 121 | lipid oxidation (GO:0034440) | 2.70735795 |
| 122 | blood vessel remodeling (GO:0001974) | 2.70149290 |
| 123 | cellular ketone body metabolic process (GO:0046950) | 2.69179964 |
| 124 | negative regulation of platelet activation (GO:0010544) | 2.68933527 |
| 125 | low-density lipoprotein particle clearance (GO:0034383) | 2.66727774 |
| 126 | plasma lipoprotein particle clearance (GO:0034381) | 2.66616894 |
| 127 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 2.65756764 |
| 128 | negative regulation of endothelial cell migration (GO:0010596) | 2.65607733 |
| 129 | substrate-dependent cell migration (GO:0006929) | 2.65515198 |
| 130 | artery development (GO:0060840) | 2.65061614 |
| 131 | positive regulation of endothelial cell migration (GO:0010595) | 2.64694989 |
| 132 | blood vessel morphogenesis (GO:0048514) | 2.64657281 |
| 133 | bile acid biosynthetic process (GO:0006699) | 2.64656747 |
| 134 | triglyceride homeostasis (GO:0070328) | 2.64473557 |
| 135 | acylglycerol homeostasis (GO:0055090) | 2.64473557 |
| 136 | acetyl-CoA metabolic process (GO:0006084) | 2.64062772 |
| 137 | regulation of fatty acid oxidation (GO:0046320) | 2.63883497 |
| 138 | embryonic heart tube development (GO:0035050) | 2.63816259 |
| 139 | cell adhesion mediated by integrin (GO:0033627) | 2.63810906 |
| 140 | cell migration involved in heart development (GO:0060973) | 2.63014463 |
| 141 | ventricular cardiac muscle tissue morphogenesis (GO:0055010) | 2.62358436 |
| 142 | regulation of vascular permeability (GO:0043114) | 2.62299005 |
| 143 | negative regulation of vascular permeability (GO:0043116) | 2.61625194 |
| 144 | Rap protein signal transduction (GO:0032486) | 2.61570305 |
| 145 | mRNA transcription (GO:0009299) | 2.60482100 |
| 146 | regulation of epithelial cell migration (GO:0010632) | 2.60351485 |
| 147 | neuron remodeling (GO:0016322) | 2.58650815 |
| 148 | regulation of angiogenesis (GO:0045765) | 2.49714453 |
| 149 | regulation of synapse maturation (GO:0090128) | 2.47709649 |
| 150 | ganglion development (GO:0061548) | 2.47350825 |
| 151 | positive regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030949) | 2.46487750 |
| 152 | atrioventricular valve morphogenesis (GO:0003181) | 2.46427809 |
| 153 | negative regulation of endothelial cell apoptotic process (GO:2000352) | 2.43701622 |
| 154 | endocardial cushion morphogenesis (GO:0003203) | 2.42788245 |
| 155 | regulation of vasculature development (GO:1901342) | 2.42250094 |
| 156 | endothelial cell development (GO:0001885) | 2.39653334 |
| 157 | positive regulation of adherens junction organization (GO:1903393) | 2.37408569 |
| 158 | regulation of endothelial cell proliferation (GO:0001936) | 2.37082927 |
| 159 | positive regulation of cell junction assembly (GO:1901890) | 2.36446585 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 5.92535892 |
| 2 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 5.17659410 |
| 3 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 4.05221452 |
| 4 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 3.69268906 |
| 5 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 3.60730124 |
| 6 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 3.02788688 |
| 7 | CLOCK_20551151_ChIP-Seq_293T_Human | 3.00139859 |
| 8 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.94482777 |
| 9 | * NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.75785281 |
| 10 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 2.64413342 |
| 11 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 2.63526790 |
| 12 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.40062651 |
| 13 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 2.18917155 |
| 14 | ZNF263_19887448_ChIP-Seq_K562_Human | 2.14378284 |
| 15 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.13217393 |
| 16 | * TBX20_22080862_ChIP-Seq_HEART_Mouse | 2.01459279 |
| 17 | * TBX20_22328084_ChIP-Seq_HEART_Mouse | 2.01459279 |
| 18 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.96119486 |
| 19 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.95643678 |
| 20 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.90053024 |
| 21 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.86477491 |
| 22 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.79607867 |
| 23 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.76061314 |
| 24 | GATA1_22025678_ChIP-Seq_K562_Human | 1.72417058 |
| 25 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.70505995 |
| 26 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.67861660 |
| 27 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.66880349 |
| 28 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.65254380 |
| 29 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.60657998 |
| 30 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.57716929 |
| 31 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.57102950 |
| 32 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.54968213 |
| 33 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.54042029 |
| 34 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.53984439 |
| 35 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.53359423 |
| 36 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.48550320 |
| 37 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.44018010 |
| 38 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.41373724 |
| 39 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.41175529 |
| 40 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.39761365 |
| 41 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.37307819 |
| 42 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.34646175 |
| 43 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.33925117 |
| 44 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.33410664 |
| 45 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.33279005 |
| 46 | GATA1_19941826_ChIP-Seq_K562_Human | 1.32783630 |
| 47 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.32168549 |
| 48 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.30851013 |
| 49 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.30174261 |
| 50 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.28679192 |
| 51 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.28268646 |
| 52 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.28199797 |
| 53 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.27033071 |
| 54 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.23520687 |
| 55 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.23050883 |
| 56 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.22585889 |
| 57 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.22541478 |
| 58 | CJUN_26792858_Chip-Seq_BT549_Human | 1.20380377 |
| 59 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.18784440 |
| 60 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.17987043 |
| 61 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.17159215 |
| 62 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.16330286 |
| 63 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.14737172 |
| 64 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.14612475 |
| 65 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.14478915 |
| 66 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.11324093 |
| 67 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.10932934 |
| 68 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.09665316 |
| 69 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.08859254 |
| 70 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.07887617 |
| 71 | SPI1_23127762_ChIP-Seq_K562_Human | 1.06025113 |
| 72 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.05121881 |
| 73 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.04491235 |
| 74 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.04367949 |
| 75 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.03359409 |
| 76 | * SMC1_22415368_ChIP-Seq_MEFs_Mouse | 1.03178355 |
| 77 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.02458481 |
| 78 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.00375461 |
| 79 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.99123338 |
| 80 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.99123338 |
| 81 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 0.98973556 |
| 82 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.98825770 |
| 83 | * SMC3_22415368_ChIP-Seq_MEFs_Mouse | 0.98597140 |
| 84 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 0.98472150 |
| 85 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 0.97721536 |
| 86 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.97571684 |
| 87 | ISL1_27105846_Chip-Seq_CPCs_Mouse | 0.96963332 |
| 88 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.96842527 |
| 89 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.96167958 |
| 90 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 0.95926613 |
| 91 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 0.95764756 |
| 92 | * GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.95626319 |
| 93 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.95197328 |
| 94 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.95079656 |
| 95 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.94610827 |
| 96 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.94220034 |
| 97 | RUNX_20019798_ChIP-Seq_JUKART_Human | 0.94197486 |
| 98 | GATA2_19941826_ChIP-Seq_K562_Human | 0.93822236 |
| 99 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 0.93776552 |
| 100 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.93011552 |
| 101 | TP53_22127205_ChIP-Seq_IMR90_Human | 0.92629776 |
| 102 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 0.91658093 |
| 103 | * TP53_23651856_ChIP-Seq_MEFs_Mouse | 0.91397498 |
| 104 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 0.90773664 |
| 105 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 0.90773664 |
| 106 | * MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.89718322 |
| 107 | VDR_24763502_ChIP-Seq_THP-1_Human | 0.89577101 |
| 108 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.89573697 |
| 109 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.88259993 |
| 110 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.87578269 |
| 111 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.87187690 |
| 112 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.85560404 |
| 113 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.85408968 |
| 114 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 0.85405257 |
| 115 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.85294388 |
| 116 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 0.85271280 |
| 117 | KDM2B_26808549_Chip-Seq_K562_Human | 0.85199342 |
| 118 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.85014084 |
| 119 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.84793009 |
| 120 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.84686152 |
| 121 | * STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.83714798 |
| 122 | * P68_20966046_ChIP-Seq_HELA_Human | 0.83613398 |
| 123 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.82395113 |
| 124 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 0.81899497 |
| 125 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.81695891 |
| 126 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.81594993 |
| 127 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 0.81524710 |
| 128 | MYC_27129775_Chip-Seq_CORNEA_Mouse | 0.81381155 |
| 129 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.81274153 |
| 130 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.81187200 |
| 131 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.80733055 |
| 132 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.80582913 |
| 133 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.80089284 |
| 134 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.79350048 |
| 135 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.79144859 |
| 136 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.78924420 |
| 137 | * NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.78793285 |
| 138 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.78144907 |
| 139 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.78036336 |
| 140 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.77233094 |
| 141 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.76859967 |
| 142 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.76501382 |
| 143 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 0.74857329 |
| 144 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 0.74180088 |
| 145 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.73799210 |
| 146 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.73708286 |
| 147 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.73650450 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0010368_abnormal_lymphatic_system | 6.55221757 |
| 2 | MP0001879_abnormal_lymphatic_vessel | 4.68008376 |
| 3 | MP0004272_abnormal_basement_membrane | 4.50866701 |
| 4 | MP0004084_abnormal_cardiac_muscle | 3.75818540 |
| 5 | MP0005360_urolithiasis | 3.40538812 |
| 6 | MP0005409_darkened_coat_color | 2.99683806 |
| 7 | MP0002139_abnormal_hepatobiliary_system | 2.95578401 |
| 8 | MP0005167_abnormal_blood-brain_barrier | 2.95265401 |
| 9 | MP0002837_dystrophic_cardiac_calcinosis | 2.86995098 |
| 10 | MP0004215_abnormal_myocardial_fiber | 2.72205601 |
| 11 | MP0005085_abnormal_gallbladder_physiolo | 2.66460545 |
| 12 | MP0004036_abnormal_muscle_relaxation | 2.55152898 |
| 13 | MP0000465_gastrointestinal_hemorrhage | 2.54317278 |
| 14 | MP0005365_abnormal_bile_salt | 2.38682079 |
| 15 | MP0003705_abnormal_hypodermis_morpholog | 2.15076818 |
| 16 | MP0006138_congestive_heart_failure | 2.08755134 |
| 17 | MP0005330_cardiomyopathy | 2.07869559 |
| 18 | MP0003828_pulmonary_edema | 2.06287164 |
| 19 | MP0000751_myopathy | 2.06174462 |
| 20 | MP0004130_abnormal_muscle_cell | 1.92230826 |
| 21 | MP0008775_abnormal_heart_ventricle | 1.90197107 |
| 22 | MP0003724_increased_susceptibility_to | 1.83741361 |
| 23 | MP0003252_abnormal_bile_duct | 1.83467034 |
| 24 | MP0002972_abnormal_cardiac_muscle | 1.81115815 |
| 25 | MP0001544_abnormal_cardiovascular_syste | 1.78992549 |
| 26 | MP0005385_cardiovascular_system_phenoty | 1.78992549 |
| 27 | MP0002138_abnormal_hepatobiliary_system | 1.76604674 |
| 28 | MP0008875_abnormal_xenobiotic_pharmacok | 1.76244972 |
| 29 | MP0010630_abnormal_cardiac_muscle | 1.72343686 |
| 30 | MP0000013_abnormal_adipose_tissue | 1.72031166 |
| 31 | MP0006054_spinal_hemorrhage | 1.71278987 |
| 32 | MP0003279_aneurysm | 1.69867875 |
| 33 | MP0010329_abnormal_lipoprotein_level | 1.67839334 |
| 34 | MP0000767_abnormal_smooth_muscle | 1.61208947 |
| 35 | MP0004782_abnormal_surfactant_physiolog | 1.59516515 |
| 36 | MP0005165_increased_susceptibility_to | 1.55217857 |
| 37 | MP0004085_abnormal_heartbeat | 1.47955376 |
| 38 | MP0005620_abnormal_muscle_contractility | 1.47803457 |
| 39 | MP0005623_abnormal_meninges_morphology | 1.46628425 |
| 40 | MP0004484_altered_response_of | 1.46079755 |
| 41 | MP0004087_abnormal_muscle_fiber | 1.45499178 |
| 42 | MP0002933_joint_inflammation | 1.44867029 |
| 43 | MP0002332_abnormal_exercise_endurance | 1.44099446 |
| 44 | MP0005332_abnormal_amino_acid | 1.41571294 |
| 45 | MP0002127_abnormal_cardiovascular_syste | 1.41540913 |
| 46 | MP0003566_abnormal_cell_adhesion | 1.40485641 |
| 47 | MP0002128_abnormal_blood_circulation | 1.40129781 |
| 48 | MP0005670_abnormal_white_adipose | 1.36068430 |
| 49 | MP0000749_muscle_degeneration | 1.33102830 |
| 50 | MP0000230_abnormal_systemic_arterial | 1.26542995 |
| 51 | MP0003646_muscle_fatigue | 1.22129080 |
| 52 | MP0003191_abnormal_cellular_cholesterol | 1.17528258 |
| 53 | MP0000750_abnormal_muscle_regeneration | 1.16689012 |
| 54 | MP0005595_abnormal_vascular_smooth | 1.15730394 |
| 55 | MP0005275_abnormal_skin_tensile | 1.15424965 |
| 56 | MP0002295_abnormal_pulmonary_circulatio | 1.15349132 |
| 57 | MP0004147_increased_porphyrin_level | 1.13871070 |
| 58 | MP0005083_abnormal_biliary_tract | 1.08962971 |
| 59 | MP0003300_gastrointestinal_ulcer | 1.07971660 |
| 60 | MP0000343_altered_response_to | 1.07862500 |
| 61 | MP0003806_abnormal_nucleotide_metabolis | 1.07677835 |
| 62 | MP0003137_abnormal_impulse_conducting | 1.06654698 |
| 63 | MP0005319_abnormal_enzyme/_coenzyme | 1.06564702 |
| 64 | MP0001614_abnormal_blood_vessel | 1.04861944 |
| 65 | MP0000249_abnormal_blood_vessel | 1.04722145 |
| 66 | MP0005666_abnormal_adipose_tissue | 1.04267441 |
| 67 | MP0009643_abnormal_urine_homeostasis | 1.03677326 |
| 68 | MP0004510_myositis | 1.03219211 |
| 69 | MP0002925_abnormal_cardiovascular_devel | 1.01544674 |
| 70 | MP0000003_abnormal_adipose_tissue | 1.00206646 |
| 71 | MP0000266_abnormal_heart_morphology | 0.99030453 |
| 72 | MP0005187_abnormal_penis_morphology | 0.98862064 |
| 73 | MP0002118_abnormal_lipid_homeostasis | 0.98231086 |
| 74 | MP0005503_abnormal_tendon_morphology | 0.97208354 |
| 75 | MP0000609_abnormal_liver_physiology | 0.93784852 |
| 76 | MP0001661_extended_life_span | 0.91658355 |
| 77 | MP0004185_abnormal_adipocyte_glucose | 0.90716307 |
| 78 | MP0009840_abnormal_foam_cell | 0.90602294 |
| 79 | MP0005375_adipose_tissue_phenotype | 0.90556047 |
| 80 | MP0001849_ear_inflammation | 0.86514548 |
| 81 | MP0002269_muscular_atrophy | 0.85853618 |
| 82 | MP0002106_abnormal_muscle_physiology | 0.83649129 |
| 83 | MP0008438_abnormal_cutaneous_collagen | 0.81638917 |
| 84 | MP0001915_intracranial_hemorrhage | 0.81390471 |
| 85 | MP0009697_abnormal_copulation | 0.79805415 |
| 86 | MP0001756_abnormal_urination | 0.79056063 |
| 87 | MP0001666_abnormal_nutrient_absorption | 0.77768290 |
| 88 | MP0003567_abnormal_fetal_cardiomyocyte | 0.77304659 |
| 89 | MP0001958_emphysema | 0.74515303 |
| 90 | MP0002133_abnormal_respiratory_system | 0.74321032 |
| 91 | MP0005388_respiratory_system_phenotype | 0.74321032 |
| 92 | MP0005084_abnormal_gallbladder_morpholo | 0.74311307 |
| 93 | MP0002108_abnormal_muscle_morphology | 0.73365547 |
| 94 | MP0003195_calcinosis | 0.71029813 |
| 95 | MP0003091_abnormal_cell_migration | 0.70395728 |
| 96 | MP0001986_abnormal_taste_sensitivity | 0.70381821 |
| 97 | MP0001784_abnormal_fluid_regulation | 0.68219986 |
| 98 | MP0003950_abnormal_plasma_membrane | 0.66997669 |
| 99 | MP0005369_muscle_phenotype | 0.66133241 |
| 100 | MP0002998_abnormal_bone_remodeling | 0.65781246 |
| 101 | MP0003948_abnormal_gas_homeostasis | 0.65458471 |
| 102 | MP0005164_abnormal_response_to | 0.63491948 |
| 103 | MP0000747_muscle_weakness | 0.62850114 |
| 104 | MP0003221_abnormal_cardiomyocyte_apopto | 0.62530016 |
| 105 | MP0004019_abnormal_vitamin_homeostasis | 0.61760666 |
| 106 | MP0000759_abnormal_skeletal_muscle | 0.60961788 |
| 107 | MP0005023_abnormal_wound_healing | 0.60827508 |
| 108 | MP0009780_abnormal_chondrocyte_physiolo | 0.60799093 |
| 109 | MP0002136_abnormal_kidney_physiology | 0.60728056 |
| 110 | MP0005058_abnormal_lysosome_morphology | 0.60071439 |
| 111 | MP0000598_abnormal_liver_morphology | 0.59382968 |
| 112 | MP0002971_abnormal_brown_adipose | 0.57835276 |
| 113 | MP0009384_cardiac_valve_regurgitation | 0.57228335 |
| 114 | MP0004145_abnormal_muscle_electrophysio | 0.56387088 |
| 115 | MP0003303_peritoneal_inflammation | 0.56149996 |
| 116 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.54873098 |
| 117 | MP0002896_abnormal_bone_mineralization | 0.53362482 |
| 118 | MP0001533_abnormal_skeleton_physiology | 0.52044612 |
| 119 | MP0002638_abnormal_pupillary_reflex | 0.50917195 |
| 120 | MP0003045_fibrosis | 0.47775878 |
| 121 | MP0000733_abnormal_muscle_development | 0.46919085 |
| 122 | MP0002877_abnormal_melanocyte_morpholog | 0.45529714 |
| 123 | MP0008874_decreased_physiological_sensi | 0.45139855 |
| 124 | MP0002086_abnormal_extraembryonic_tissu | 0.44683123 |
| 125 | MP0005508_abnormal_skeleton_morphology | 0.44623572 |
| 126 | MP0008004_abnormal_stomach_pH | 0.43548010 |
| 127 | MP0005451_abnormal_body_composition | 0.41476520 |
| 128 | MP0003943_abnormal_hepatobiliary_system | 0.40891149 |
| 129 | MP0001175_abnormal_lung_morphology | 0.39858526 |
| 130 | MP0003638_abnormal_response/metabolism_ | 0.38045890 |
| 131 | MP0003935_abnormal_craniofacial_develop | 0.37460118 |
| 132 | MP0004883_abnormal_blood_vessel | 0.36097689 |
| 133 | MP0005390_skeleton_phenotype | 0.35545512 |
| 134 | MP0003283_abnormal_digestive_organ | 0.35058040 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Deep venous thrombosis (HP:0002625) | 5.28152129 |
| 2 | Polycythemia (HP:0001901) | 4.85883638 |
| 3 | Sudden death (HP:0001699) | 4.58811644 |
| 4 | Ventricular tachycardia (HP:0004756) | 4.49036767 |
| 5 | Hemiplegia (HP:0002301) | 4.12429449 |
| 6 | Lymphangioma (HP:0100764) | 4.08725407 |
| 7 | Muscle fiber splitting (HP:0003555) | 3.96204827 |
| 8 | Right ventricular cardiomyopathy (HP:0011663) | 3.95062736 |
| 9 | Esophageal varix (HP:0002040) | 3.88614335 |
| 10 | Porencephaly (HP:0002132) | 3.84916832 |
| 11 | Hyporeflexia of lower limbs (HP:0002600) | 3.74309773 |
| 12 | Adactyly (HP:0009776) | 3.70706754 |
| 13 | Tetraparesis (HP:0002273) | 3.63701779 |
| 14 | Hematochezia (HP:0002573) | 3.60578389 |
| 15 | Capillary hemangiomas (HP:0005306) | 3.52257108 |
| 16 | Hypoglycemic coma (HP:0001325) | 3.50736755 |
| 17 | Spontaneous hematomas (HP:0007420) | 3.49807031 |
| 18 | Mesangial abnormality (HP:0001966) | 3.45208985 |
| 19 | Intrahepatic cholestasis (HP:0001406) | 3.45151461 |
| 20 | Skull defect (HP:0001362) | 3.41611202 |
| 21 | Atrial fibrillation (HP:0005110) | 3.40159979 |
| 22 | Increased connective tissue (HP:0009025) | 3.26553479 |
| 23 | Xanthomatosis (HP:0000991) | 3.25759399 |
| 24 | Abnormality of the hepatic vasculature (HP:0006707) | 3.24983279 |
| 25 | Broad metatarsal (HP:0001783) | 3.24607816 |
| 26 | Supraventricular arrhythmia (HP:0005115) | 3.19150513 |
| 27 | Cerebral hemorrhage (HP:0001342) | 3.17658727 |
| 28 | Arterial tortuosity (HP:0005116) | 3.13746965 |
| 29 | Primary atrial arrhythmia (HP:0001692) | 3.11669124 |
| 30 | Focal segmental glomerulosclerosis (HP:0000097) | 3.08075121 |
| 31 | Visceral angiomatosis (HP:0100761) | 3.07921355 |
| 32 | Lipoatrophy (HP:0100578) | 3.06960871 |
| 33 | Wrist flexion contracture (HP:0001239) | 3.06845207 |
| 34 | Nonimmune hydrops fetalis (HP:0001790) | 3.06026322 |
| 35 | Hypoalphalipoproteinemia (HP:0003233) | 3.00215793 |
| 36 | Absent hand (HP:0004050) | 2.99197399 |
| 37 | Prolonged partial thromboplastin time (HP:0003645) | 2.96493369 |
| 38 | Ketoacidosis (HP:0001993) | 2.96298887 |
| 39 | Atrioventricular block (HP:0001678) | 2.95772090 |
| 40 | Hyperlipoproteinemia (HP:0010980) | 2.94835190 |
| 41 | Supraventricular tachycardia (HP:0004755) | 2.94642323 |
| 42 | Difficulty running (HP:0009046) | 2.94308090 |
| 43 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.93866695 |
| 44 | Ketosis (HP:0001946) | 2.92103665 |
| 45 | Hypoplasia of the iris (HP:0007676) | 2.87621942 |
| 46 | Hemangiomatosis (HP:0007461) | 2.85943500 |
| 47 | Hyperammonemia (HP:0001987) | 2.84681100 |
| 48 | Cerebral aneurysm (HP:0004944) | 2.84026279 |
| 49 | Vascular tortuosity (HP:0004948) | 2.83387180 |
| 50 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.81473462 |
| 51 | Spinal rigidity (HP:0003306) | 2.80118946 |
| 52 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.77997103 |
| 53 | Systemic lupus erythematosus (HP:0002725) | 2.73816024 |
| 54 | Hemorrhage of the eye (HP:0011885) | 2.73006207 |
| 55 | Premature rupture of membranes (HP:0001788) | 2.71368984 |
| 56 | Syncope (HP:0001279) | 2.71102801 |
| 57 | Exercise-induced muscle cramps (HP:0003710) | 2.69225205 |
| 58 | Calf muscle hypertrophy (HP:0008981) | 2.69084765 |
| 59 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.68946726 |
| 60 | Myoglobinuria (HP:0002913) | 2.68508081 |
| 61 | Aortic aneurysm (HP:0004942) | 2.67267575 |
| 62 | Cavernous hemangioma (HP:0001048) | 2.64295889 |
| 63 | Distal arthrogryposis (HP:0005684) | 2.59973599 |
| 64 | Exercise-induced myalgia (HP:0003738) | 2.59918622 |
| 65 | Dilated cardiomyopathy (HP:0001644) | 2.59145891 |
| 66 | Abnormality of the intrinsic pathway (HP:0010989) | 2.56717287 |
| 67 | Hyperglycinuria (HP:0003108) | 2.56708563 |
| 68 | Joint hemorrhage (HP:0005261) | 2.55684160 |
| 69 | Conjunctival telangiectasia (HP:0000524) | 2.53005883 |
| 70 | Hypolipoproteinemia (HP:0010981) | 2.52209574 |
| 71 | Overgrowth (HP:0001548) | 2.51716673 |
| 72 | Glomerulosclerosis (HP:0000096) | 2.51263677 |
| 73 | Heart block (HP:0012722) | 2.46861228 |
| 74 | Aneurysm (HP:0002617) | 2.46380283 |
| 75 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.41991504 |
| 76 | Abnormality of the common coagulation pathway (HP:0010990) | 2.39815610 |
| 77 | Complement deficiency (HP:0004431) | 2.39720100 |
| 78 | Nephritis (HP:0000123) | 2.38889036 |
| 79 | Palpitations (HP:0001962) | 2.36654845 |
| 80 | Lymphedema (HP:0001004) | 2.35625235 |
| 81 | Muscle hypertrophy of the lower extremities (HP:0008968) | 2.32199352 |
| 82 | Abnormal atrioventricular conduction (HP:0005150) | 2.31035047 |
| 83 | Round ear (HP:0100830) | 2.30253994 |
| 84 | Venous insufficiency (HP:0005293) | 2.29463426 |
| 85 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.28033479 |
| 86 | Dicarboxylic aciduria (HP:0003215) | 2.28033479 |
| 87 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.25801934 |
| 88 | Abnormality of glycine metabolism (HP:0010895) | 2.25801934 |
| 89 | Abnormality of complement system (HP:0005339) | 2.25150709 |
| 90 | Neonatal death (HP:0003811) | 2.25078133 |
| 91 | Hypobetalipoproteinemia (HP:0003563) | 2.23407678 |
| 92 | Abnormality of the calf musculature (HP:0001430) | 2.22860012 |
| 93 | EMG: myopathic abnormalities (HP:0003458) | 2.22382067 |
| 94 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.20583734 |
| 95 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.19359182 |
| 96 | Asymmetric septal hypertrophy (HP:0001670) | 2.17511378 |
| 97 | Cardiovascular calcification (HP:0011915) | 2.16546579 |
| 98 | Abnormality of the ischium (HP:0003174) | 2.15591976 |
| 99 | Joint stiffness (HP:0001387) | 2.13185852 |
| 100 | Pulmonary hypertension (HP:0002092) | 2.12952421 |
| 101 | Hypoplastic ischia (HP:0003175) | 2.12902368 |
| 102 | Hip contracture (HP:0003273) | 2.12801869 |
| 103 | Interstitial pulmonary disease (HP:0006530) | 2.12587843 |
| 104 | Rhabdomyolysis (HP:0003201) | 2.11407742 |
| 105 | Venous abnormality (HP:0002624) | 2.10549325 |
| 106 | Shallow orbits (HP:0000586) | 2.10511726 |
| 107 | Stroke (HP:0001297) | 2.10418081 |
| 108 | Exotropia (HP:0000577) | 2.10008089 |
| 109 | Abnormality of the nasal mucosa (HP:0000433) | 2.08255044 |
| 110 | Vascular calcification (HP:0004934) | 2.07551880 |
| 111 | Prolonged QT interval (HP:0001657) | 2.07135457 |
| 112 | Short 4th metacarpal (HP:0010044) | 2.06302427 |
| 113 | Aplasia/Hypoplasia of the 4th metacarpal (HP:0010042) | 2.06302427 |
| 114 | Nuclear cataract (HP:0100018) | 2.06218086 |
| 115 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 2.05339654 |
| 116 | Abnormality of the left ventricular outflow tract (HP:0011103) | 2.05191323 |
| 117 | Subaortic stenosis (HP:0001682) | 2.05191323 |
| 118 | Skin nodule (HP:0200036) | 2.05150684 |
| 119 | Epidermoid cyst (HP:0200040) | 2.05095632 |
| 120 | Portal hypertension (HP:0001409) | 2.04732981 |
| 121 | Glomerulonephritis (HP:0000099) | 2.03020865 |
| 122 | Aortic dissection (HP:0002647) | 2.02778722 |
| 123 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.01832741 |
| 124 | Bundle branch block (HP:0011710) | 1.99491685 |
| 125 | Increased variability in muscle fiber diameter (HP:0003557) | 1.99314777 |
| 126 | Protrusio acetabuli (HP:0003179) | 1.98419470 |
| 127 | Distal lower limb muscle weakness (HP:0009053) | 1.97173411 |
| 128 | Myotonia (HP:0002486) | 1.97160118 |
| 129 | Delayed CNS myelination (HP:0002188) | 1.97079774 |
| 130 | Hyperglycinemia (HP:0002154) | 1.95922817 |
| 131 | Ulnar deviation of the wrist (HP:0003049) | 1.95664697 |
| 132 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 1.95255356 |
| 133 | Ventricular arrhythmia (HP:0004308) | 1.94865768 |
| 134 | Difficulty climbing stairs (HP:0003551) | 1.94073136 |
| 135 | Potter facies (HP:0002009) | 1.93679338 |
| 136 | Facial shape deformation (HP:0011334) | 1.93679338 |
| 137 | Limited hip movement (HP:0008800) | 1.93635602 |
| 138 | Hypercholesterolemia (HP:0003124) | 1.90435778 |
| 139 | Type 1 muscle fiber predominance (HP:0003803) | 1.88665586 |
| 140 | Malignant hyperthermia (HP:0002047) | 1.88531045 |
| 141 | Myocardial infarction (HP:0001658) | 1.85891700 |
| 142 | Abnormal vertebral ossification (HP:0100569) | 1.82691459 |
| 143 | Mask-like facies (HP:0000298) | 1.80824740 |
| 144 | Polygenic inheritance (HP:0010982) | 1.80159440 |
| 145 | Ectopia lentis (HP:0001083) | 1.80014254 |
| 146 | Striae distensae (HP:0001065) | 1.74951697 |
| 147 | Abnormality of the peritoneum (HP:0002585) | 1.73273905 |
| 148 | Rapidly progressive (HP:0003678) | 1.71827091 |
| 149 | Joint contractures involving the joints of the feet (HP:0100492) | 1.71514542 |
| 150 | Flexion contracture of toe (HP:0005830) | 1.71514542 |
| 151 | Absent eyebrow (HP:0002223) | 1.70132365 |
| 152 | Limb dystonia (HP:0002451) | 1.70007154 |
| 153 | Abnormality of the periventricular white matter (HP:0002518) | 1.66483637 |
| 154 | Axonal loss (HP:0003447) | 1.66397679 |
| 155 | Bulbous nose (HP:0000414) | 1.64643286 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TIE1 | 8.89749567 |
| 2 | KDR | 7.02321825 |
| 3 | TGFBR2 | 3.50402518 |
| 4 | FES | 2.66637058 |
| 5 | TGFBR1 | 2.32277241 |
| 6 | MYLK | 2.28755123 |
| 7 | TTN | 2.23400675 |
| 8 | TRIB3 | 2.18691116 |
| 9 | EPHB2 | 2.15052681 |
| 10 | PKN2 | 2.07644210 |
| 11 | RIPK1 | 1.97240549 |
| 12 | BCKDK | 1.71438354 |
| 13 | FGFR4 | 1.68859562 |
| 14 | PDGFRA | 1.64499564 |
| 15 | ERN1 | 1.61418904 |
| 16 | PTK2B | 1.53128784 |
| 17 | DMPK | 1.48741406 |
| 18 | PTK6 | 1.40730602 |
| 19 | PDK2 | 1.33137448 |
| 20 | SIK1 | 1.31334561 |
| 21 | WNK4 | 1.29985137 |
| 22 | EPHB1 | 1.28023617 |
| 23 | FER | 1.24370344 |
| 24 | INSRR | 1.23966706 |
| 25 | LATS1 | 1.19682727 |
| 26 | NTRK1 | 1.19326447 |
| 27 | LMTK2 | 1.17841450 |
| 28 | OBSCN | 1.17309918 |
| 29 | PDK3 | 1.16937499 |
| 30 | PDK4 | 1.16937499 |
| 31 | PHKG1 | 1.13984415 |
| 32 | PHKG2 | 1.13984415 |
| 33 | FGFR2 | 1.08976306 |
| 34 | MAP2K3 | 1.05538419 |
| 35 | MAP3K13 | 1.03537695 |
| 36 | MAPK12 | 1.02055180 |
| 37 | PRKD1 | 0.98751885 |
| 38 | MAP3K3 | 0.97438029 |
| 39 | ICK | 0.94080787 |
| 40 | GRK1 | 0.91741696 |
| 41 | ZAP70 | 0.91393936 |
| 42 | MARK2 | 0.88959130 |
| 43 | PRKG2 | 0.86304015 |
| 44 | MAP4K1 | 0.82162995 |
| 45 | FGFR3 | 0.80372475 |
| 46 | PRKD3 | 0.79118804 |
| 47 | PRKD2 | 0.78037066 |
| 48 | PAK3 | 0.77704021 |
| 49 | LRRK2 | 0.76521769 |
| 50 | PRKAA2 | 0.76487636 |
| 51 | RPS6KA2 | 0.75212345 |
| 52 | PIK3CG | 0.74838584 |
| 53 | MOS | 0.74112450 |
| 54 | PTK2 | 0.73660413 |
| 55 | BLK | 0.72116360 |
| 56 | PIK3CA | 0.71679557 |
| 57 | STK39 | 0.70812771 |
| 58 | ARAF | 0.69509500 |
| 59 | MAP3K7 | 0.68726813 |
| 60 | MAPK15 | 0.67661860 |
| 61 | ROCK1 | 0.65715621 |
| 62 | TYRO3 | 0.64859940 |
| 63 | MET | 0.64436579 |
| 64 | PAK4 | 0.63715711 |
| 65 | PDGFRB | 0.63434441 |
| 66 | RET | 0.60325477 |
| 67 | PRKCH | 0.57342537 |
| 68 | GSK3A | 0.56286242 |
| 69 | EEF2K | 0.56249958 |
| 70 | MAP3K9 | 0.55471535 |
| 71 | PDPK1 | 0.55428130 |
| 72 | JAK1 | 0.54972082 |
| 73 | CAMK4 | 0.52240476 |
| 74 | HCK | 0.51710537 |
| 75 | FLT3 | 0.50578650 |
| 76 | MAP3K6 | 0.50524842 |
| 77 | PAK2 | 0.49946082 |
| 78 | CSK | 0.48546169 |
| 79 | MAP3K10 | 0.48141989 |
| 80 | JAK3 | 0.47790245 |
| 81 | DYRK1B | 0.47357646 |
| 82 | EPHA3 | 0.47300793 |
| 83 | NEK9 | 0.46543464 |
| 84 | PRKAA1 | 0.44805945 |
| 85 | ITK | 0.44154494 |
| 86 | JAK2 | 0.44015112 |
| 87 | ROCK2 | 0.43582087 |
| 88 | DDR2 | 0.43188261 |
| 89 | MAP3K1 | 0.42873282 |
| 90 | IGF1R | 0.41088741 |
| 91 | MAPK7 | 0.40775367 |
| 92 | ILK | 0.39837778 |
| 93 | MAP3K11 | 0.39684779 |
| 94 | MAP2K1 | 0.38716023 |
| 95 | KSR2 | 0.38332766 |
| 96 | CAMK1D | 0.38076355 |
| 97 | LATS2 | 0.37859973 |
| 98 | MTOR | 0.37685835 |
| 99 | SGK2 | 0.36362220 |
| 100 | TYK2 | 0.36296614 |
| 101 | SGK494 | 0.36145462 |
| 102 | SGK223 | 0.36145462 |
| 103 | STK10 | 0.35511471 |
| 104 | FRK | 0.35215024 |
| 105 | PRKCE | 0.35030785 |
| 106 | SRC | 0.34267532 |
| 107 | EGFR | 0.33280351 |
| 108 | CAMK1G | 0.32672140 |
| 109 | CDC42BPA | 0.29990611 |
| 110 | GRK5 | 0.29946517 |
| 111 | SGK3 | 0.29809538 |
| 112 | ABL2 | 0.29594607 |
| 113 | OXSR1 | 0.29323770 |
| 114 | MAPK11 | 0.29127053 |
| 115 | FGFR1 | 0.28783991 |
| 116 | PRKACG | 0.27632998 |
| 117 | TEC | 0.27553803 |
| 118 | PRKACB | 0.27500450 |
| 119 | LCK | 0.27135744 |
| 120 | AKT2 | 0.26948565 |
| 121 | MARK3 | 0.26784166 |
| 122 | PDK1 | 0.26722944 |
| 123 | AKT3 | 0.26585507 |
| 124 | MAP2K4 | 0.25321474 |
| 125 | MAPKAPK3 | 0.25302046 |
| 126 | TBK1 | 0.24922867 |
| 127 | MAP2K2 | 0.23871830 |
| 128 | ADRBK1 | 0.23675029 |
| 129 | MAPK4 | 0.22105619 |
| 130 | KIT | 0.22020868 |
| 131 | TRPM7 | 0.21192453 |
| 132 | RPS6KC1 | 0.20714990 |
| 133 | RPS6KL1 | 0.20714990 |
| 134 | STK24 | 0.20219229 |
| 135 | PINK1 | 0.20213212 |
| 136 | TNK2 | 0.19390212 |
| 137 | ERBB4 | 0.18985746 |
| 138 | BMX | 0.18408598 |
| 139 | TESK1 | 0.16803307 |
| 140 | LYN | 0.15853451 |
| 141 | RPS6KA6 | 0.15797877 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.27732166 |
| 2 | Fatty acid degradation_Homo sapiens_hsa00071 | 3.00971869 |
| 3 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.92219767 |
| 4 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.73927688 |
| 5 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.68308506 |
| 6 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.63979476 |
| 7 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 2.57574026 |
| 8 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.56576721 |
| 9 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.48218371 |
| 10 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 2.38864414 |
| 11 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.38779091 |
| 12 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.25735230 |
| 13 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.24991620 |
| 14 | PPAR signaling pathway_Homo sapiens_hsa03320 | 2.21226501 |
| 15 | Fatty acid metabolism_Homo sapiens_hsa01212 | 2.17035368 |
| 16 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 2.14955066 |
| 17 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.13468263 |
| 18 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.92553027 |
| 19 | Prion diseases_Homo sapiens_hsa05020 | 1.83915212 |
| 20 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.78342569 |
| 21 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 1.78337221 |
| 22 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.76289467 |
| 23 | Bile secretion_Homo sapiens_hsa04976 | 1.68034179 |
| 24 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 1.60836084 |
| 25 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.54499059 |
| 26 | Peroxisome_Homo sapiens_hsa04146 | 1.45220339 |
| 27 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 1.43767877 |
| 28 | Malaria_Homo sapiens_hsa05144 | 1.40604580 |
| 29 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.38610608 |
| 30 | Focal adhesion_Homo sapiens_hsa04510 | 1.35210147 |
| 31 | Pertussis_Homo sapiens_hsa05133 | 1.34014693 |
| 32 | Ras signaling pathway_Homo sapiens_hsa04014 | 1.31883531 |
| 33 | Other glycan degradation_Homo sapiens_hsa00511 | 1.31132033 |
| 34 | Carbon metabolism_Homo sapiens_hsa01200 | 1.30719198 |
| 35 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 1.30394100 |
| 36 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.30055634 |
| 37 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.29474788 |
| 38 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.28564971 |
| 39 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.25244046 |
| 40 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.22120101 |
| 41 | Lysine degradation_Homo sapiens_hsa00310 | 1.21678878 |
| 42 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.21242071 |
| 43 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.20623926 |
| 44 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.17146115 |
| 45 | ABC transporters_Homo sapiens_hsa02010 | 1.17034216 |
| 46 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.10844811 |
| 47 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.10297128 |
| 48 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.07005099 |
| 49 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.03782627 |
| 50 | Adherens junction_Homo sapiens_hsa04520 | 1.01192077 |
| 51 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.00129409 |
| 52 | Insulin resistance_Homo sapiens_hsa04931 | 1.00009620 |
| 53 | Histidine metabolism_Homo sapiens_hsa00340 | 0.97907364 |
| 54 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.97129294 |
| 55 | Endocytosis_Homo sapiens_hsa04144 | 0.96614108 |
| 56 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.91828170 |
| 57 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.91410180 |
| 58 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.87366691 |
| 59 | Amoebiasis_Homo sapiens_hsa05146 | 0.87276503 |
| 60 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.86903215 |
| 61 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.86041930 |
| 62 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.85202379 |
| 63 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.84750659 |
| 64 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.83969210 |
| 65 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.82988140 |
| 66 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.81664202 |
| 67 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.80668800 |
| 68 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.80546071 |
| 69 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.78892988 |
| 70 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.77627314 |
| 71 | Gap junction_Homo sapiens_hsa04540 | 0.77496276 |
| 72 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.77433040 |
| 73 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.77155410 |
| 74 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.76986374 |
| 75 | Pathways in cancer_Homo sapiens_hsa05200 | 0.75523103 |
| 76 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.75415722 |
| 77 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.74982608 |
| 78 | Retinol metabolism_Homo sapiens_hsa00830 | 0.74486037 |
| 79 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.73410651 |
| 80 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.72652931 |
| 81 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.71993417 |
| 82 | Lysosome_Homo sapiens_hsa04142 | 0.71504023 |
| 83 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.70705543 |
| 84 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.68817481 |
| 85 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.67785852 |
| 86 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.67101127 |
| 87 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.67072068 |
| 88 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.66569492 |
| 89 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.65505132 |
| 90 | Glioma_Homo sapiens_hsa05214 | 0.64945744 |
| 91 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.64940380 |
| 92 | Viral myocarditis_Homo sapiens_hsa05416 | 0.64689169 |
| 93 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.63507329 |
| 94 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.62365720 |
| 95 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.62240683 |
| 96 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.61675134 |
| 97 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.60210159 |
| 98 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.59528088 |
| 99 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.59397647 |
| 100 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.57779681 |
| 101 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.57451177 |
| 102 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.56683857 |
| 103 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.56204530 |
| 104 | Tight junction_Homo sapiens_hsa04530 | 0.55488233 |
| 105 | Leishmaniasis_Homo sapiens_hsa05140 | 0.55292307 |
| 106 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.55029774 |
| 107 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.54458535 |
| 108 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.53422240 |
| 109 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.52739103 |
| 110 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.52344375 |
| 111 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.51739706 |
| 112 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.51577714 |
| 113 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.51209706 |
| 114 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.51097599 |
| 115 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.50518531 |
| 116 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.49723935 |
| 117 | Phagosome_Homo sapiens_hsa04145 | 0.49670904 |
| 118 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.49459652 |
| 119 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.48206018 |
| 120 | Salmonella infection_Homo sapiens_hsa05132 | 0.47394695 |
| 121 | Melanogenesis_Homo sapiens_hsa04916 | 0.46838768 |
| 122 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.46418293 |
| 123 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.45965565 |
| 124 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.45842405 |
| 125 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.45762822 |
| 126 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.45438042 |
| 127 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.45351297 |
| 128 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.45320992 |
| 129 | Long-term potentiation_Homo sapiens_hsa04720 | 0.45296106 |
| 130 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.44861485 |
| 131 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.44688991 |
| 132 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.44336833 |
| 133 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.43770467 |
| 134 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.43352881 |
| 135 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.43277978 |
| 136 | Platelet activation_Homo sapiens_hsa04611 | 0.42952324 |
| 137 | Morphine addiction_Homo sapiens_hsa05032 | 0.42504049 |
| 138 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.42371083 |
| 139 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.42102740 |
| 140 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.41465654 |
| 141 | Long-term depression_Homo sapiens_hsa04730 | 0.41214467 |
| 142 | Axon guidance_Homo sapiens_hsa04360 | 0.40884574 |
| 143 | Bladder cancer_Homo sapiens_hsa05219 | 0.40258124 |
| 144 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.39334295 |
| 145 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.37901386 |
| 146 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.35526382 |
| 147 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.35495456 |
| 148 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.34928402 |
| 149 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.32489710 |
| 150 | Renin secretion_Homo sapiens_hsa04924 | 0.31587433 |
| 151 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.31458531 |
| 152 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.30302897 |
| 153 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.29137755 |
| 154 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.28845413 |
| 155 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.25499289 |
| 156 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.24853415 |
| 157 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.24834887 |
| 158 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.23754104 |
| 159 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.22849163 |
| 160 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.21581747 |

